Vijay Kumar
Stock Analyst at Evercore ISI Group
(2.24)
# 2,461
Out of 5,182 analysts
282
Total ratings
41.52%
Success rate
-4.72%
Average return
Main Sectors:
Stocks Rated by Vijay Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JBHT J.B. Hunt Transport Services | Maintains: Outperform | $222 → $232 | $214.91 | +7.95% | 10 | Mar 27, 2026 | |
| CAI Caris Life Sciences | Maintains: Outperform | $38 → $34 | $19.29 | +76.26% | 3 | Feb 27, 2026 | |
| PEN Penumbra | Maintains: Outperform | $340 → $360 | $330.36 | +8.97% | 3 | Feb 26, 2026 | |
| USB U.S. Bancorp | Maintains: In-Line | $60 → $65 | $52.95 | +22.76% | 8 | Feb 5, 2026 | |
| GEHC GE HealthCare Technologies | Maintains: Outperform | $95 → $98 | $70.35 | +39.30% | 6 | Feb 5, 2026 | |
| BSX Boston Scientific | Maintains: Outperform | $112 → $96 | $62.82 | +52.82% | 8 | Feb 5, 2026 | |
| AZTA Azenta | Maintains: Outperform | $50 → $45 | $22.63 | +98.85% | 10 | Feb 5, 2026 | |
| TWST Twist Bioscience | Maintains: Outperform | $42 → $52 | $50.21 | +3.57% | 7 | Feb 3, 2026 | |
| RVTY Revvity | Maintains: Outperform | $112 → $118 | $88.94 | +32.67% | 4 | Feb 3, 2026 | |
| ISRG Intuitive Surgical | Maintains: In-Line | $580 → $550 | $452.07 | +21.66% | 15 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $144 → $138 | $102.87 | +34.15% | 18 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: In-Line | $79 → $78 | $75.65 | +3.11% | 17 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: In-Line | $18 | $16.49 | +9.16% | 12 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: In-Line | $14 → $12 | $7.90 | +51.90% | 13 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $94 → $120 | $90.89 | +32.03% | 15 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $194 → $210 | $116.80 | +79.79% | 3 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $155 → $160 | $115.48 | +38.55% | 8 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $410 → $405 | $331.54 | +22.16% | 13 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $132 → $142 | $127.38 | +11.48% | 9 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $92 | $81.05 | +13.51% | 15 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $525 → $590 | $491.46 | +20.05% | 13 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $1,275 → $1,400 | $1,259.94 | +11.12% | 12 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $226 → $245 | $191.12 | +28.19% | 4 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $31 | $16.68 | +85.85% | 8 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $103 → $106 | $86.63 | +22.36% | 5 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $48 → $46 | $22.64 | +103.18% | 4 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $3 | $3.08 | -2.60% | 6 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $18 → $30 | $10.55 | +184.36% | 11 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $335 → $355 | $304.24 | +16.68% | 8 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $160 | $91.08 | +75.67% | 7 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $286 → $290 | $154.51 | +87.69% | 6 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $1.13 | +519.47% | 1 | May 31, 2022 |
J.B. Hunt Transport Services
Mar 27, 2026
Maintains: Outperform
Price Target: $222 → $232
Current: $214.91
Upside: +7.95%
Caris Life Sciences
Feb 27, 2026
Maintains: Outperform
Price Target: $38 → $34
Current: $19.29
Upside: +76.26%
Penumbra
Feb 26, 2026
Maintains: Outperform
Price Target: $340 → $360
Current: $330.36
Upside: +8.97%
U.S. Bancorp
Feb 5, 2026
Maintains: In-Line
Price Target: $60 → $65
Current: $52.95
Upside: +22.76%
GE HealthCare Technologies
Feb 5, 2026
Maintains: Outperform
Price Target: $95 → $98
Current: $70.35
Upside: +39.30%
Boston Scientific
Feb 5, 2026
Maintains: Outperform
Price Target: $112 → $96
Current: $62.82
Upside: +52.82%
Azenta
Feb 5, 2026
Maintains: Outperform
Price Target: $50 → $45
Current: $22.63
Upside: +98.85%
Twist Bioscience
Feb 3, 2026
Maintains: Outperform
Price Target: $42 → $52
Current: $50.21
Upside: +3.57%
Revvity
Feb 3, 2026
Maintains: Outperform
Price Target: $112 → $118
Current: $88.94
Upside: +32.67%
Intuitive Surgical
Jan 23, 2026
Maintains: In-Line
Price Target: $580 → $550
Current: $452.07
Upside: +21.66%
Jan 23, 2026
Maintains: Outperform
Price Target: $144 → $138
Current: $102.87
Upside: +34.15%
Jan 5, 2026
Downgrades: In-Line
Price Target: $79 → $78
Current: $75.65
Upside: +3.11%
Jan 5, 2026
Downgrades: In-Line
Price Target: $18
Current: $16.49
Upside: +9.16%
Jan 5, 2026
Downgrades: In-Line
Price Target: $14 → $12
Current: $7.90
Upside: +51.90%
Jan 5, 2026
Upgrades: Outperform
Price Target: $94 → $120
Current: $90.89
Upside: +32.03%
Jan 5, 2026
Upgrades: Outperform
Price Target: $194 → $210
Current: $116.80
Upside: +79.79%
Jan 5, 2026
Upgrades: Outperform
Price Target: $155 → $160
Current: $115.48
Upside: +38.55%
Oct 31, 2025
Maintains: Outperform
Price Target: $410 → $405
Current: $331.54
Upside: +22.16%
Oct 31, 2025
Maintains: Outperform
Price Target: $132 → $142
Current: $127.38
Upside: +11.48%
Oct 31, 2025
Maintains: Outperform
Price Target: $88 → $92
Current: $81.05
Upside: +13.51%
Oct 7, 2025
Maintains: Outperform
Price Target: $525 → $590
Current: $491.46
Upside: +20.05%
Oct 7, 2025
Maintains: Outperform
Price Target: $1,275 → $1,400
Current: $1,259.94
Upside: +11.12%
Oct 7, 2025
Maintains: Outperform
Price Target: $226 → $245
Current: $191.12
Upside: +28.19%
Oct 7, 2025
Maintains: Outperform
Price Target: $33 → $31
Current: $16.68
Upside: +85.85%
Jul 8, 2025
Maintains: Outperform
Price Target: $103 → $106
Current: $86.63
Upside: +22.36%
Jul 8, 2025
Maintains: Outperform
Price Target: $48 → $46
Current: $22.64
Upside: +103.18%
May 19, 2025
Maintains: In-Line
Price Target: $3
Current: $3.08
Upside: -2.60%
Dec 2, 2024
Upgrades: Outperform
Price Target: $18 → $30
Current: $10.55
Upside: +184.36%
Oct 1, 2024
Maintains: In-Line
Price Target: $335 → $355
Current: $304.24
Upside: +16.68%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $160
Current: $91.08
Upside: +75.67%
Oct 1, 2024
Maintains: Outperform
Price Target: $286 → $290
Current: $154.51
Upside: +87.69%
May 31, 2022
Initiates: Outperform
Price Target: $7
Current: $1.13
Upside: +519.47%